ストックスクリーナーアプリを入手
11.27
5.61%
-0.67
アフターアワーズ：
11.27
前日終値:
$11.94
開ける：
$11.84
24時間の取引高:
171.09K
Relative Volume:
0.78
時価総額：
$125.31M
収益：
$346.10M
当期純損益:
$-20.02M
株価収益率:
-6.1828
EPS:
-1.8228
ネットキャッシュフロー:
$-1.47M
1週間 パフォーマンス:
-7.47%
1か月 パフォーマンス:
-9.70%
6か月 パフォーマンス:
-6.32%
1年 パフォーマンス:
-16.77%
1日の値動き範囲:
$11.25
$11.96
1週間の範囲:
$11.25
$12.39
52週間の値動き範囲:
$9.22
$15.46
Medifast Inc Stock (MED) Company Profile
名前
Medifast Inc
電話
(410) 581-8042
住所
1501 S. CLINTON STREET, BALTIMORE, MD
Compare MED vs ROL, SCI, FTDR, HRB, ANDG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
MED
Medifast Inc
|
11.27 | 132.76M | 346.10M | -20.02M | -1.47M | -1.8228 |
ROL
Rollins Inc
|
46.79 | 22.58B | 3.84B | 529.30M | 621.14M | 1.0945 |
SCI
Service Corp International
|
74.58 | 10.20B | 4.33B | 535.79M | 486.05M | 3.79 |
FTDR
Frontdoor Inc
|
70.13 | 4.90B | 2.12B | 260.00M | 385.00M | 3.5067 |
HRB
H R Block Inc
|
36.23 | 4.59B | 3.91B | 736.10M | 760.88M | 5.6238 |
ANDG
Andersen Group Inc
|
37.50 | 4.23B | 871.37M | -163.01M | 0 | 1.0456 |
Medifast Inc Stock (MED) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-11-05 | アップグレード | DA Davidson | Underperform → Neutral |
| 2024-06-05 | ダウングレード | DA Davidson | Neutral → Underperform |
| 2023-10-13 | 開始されました | Stephens | Equal-Weight |
| 2022-11-04 | ダウングレード | DA Davidson | Buy → Neutral |
| 2022-08-04 | ダウングレード | Jefferies | Buy → Hold |
| 2021-01-25 | アップグレード | Jefferies | Hold → Buy |
| 2020-11-05 | アップグレード | DA Davidson | Neutral → Buy |
| 2020-06-25 | 開始されました | B. Riley FBR | Buy |
| 2020-02-27 | ダウングレード | Jefferies | Buy → Hold |
| 2019-11-08 | ダウングレード | Dougherty & Company | Buy → Neutral |
| 2019-07-25 | 開始されました | Jefferies | Buy |
| 2018-11-08 | アップグレード | Sidoti | Neutral → Buy |
| 2018-03-07 | アップグレード | Sidoti | Neutral → Buy |
| 2017-09-15 | 繰り返されました | DA Davidson | Buy |
| 2016-08-04 | 繰り返されました | Wunderlich | Hold |
| 2016-01-11 | アップグレード | Sidoti | Neutral → Buy |
| 2015-11-30 | ダウングレード | Sidoti | Buy → Neutral |
| 2015-10-05 | アップグレード | Sidoti | Neutral → Buy |
| 2014-11-07 | ダウングレード | Imperial Capital | Outperform → In-line |
| 2014-08-08 | 繰り返されました | Imperial Capital | Outperform |
| 2014-04-23 | 繰り返されました | Imperial Capital | Outperform |
| 2013-09-06 | 開始されました | Imperial Capital | Outperform |
| 2012-11-06 | 繰り返されました | Northland Securities | Outperform |
| 2012-07-27 | アップグレード | Northland Securities | Market Perform → Outperform |
| 2012-07-09 | ダウングレード | Standpoint Research | Buy → Hold |
| 2012-01-30 | 開始されました | Standpoint Research | Buy |
すべてを表示
Medifast Inc (MED) 最新ニュース
New coaching twist, Medifast’s OPTAVIA app deepens its weight-loss ecosystem - AD HOC NEWS
Medifast Inc Stock (US58470S1024): valuation in focus after steep multi-year slide - AD HOC NEWS
Metabolic Health After 40: What Perimenopause and Menopause Mean for Weight Management - GlobeNewswire
Medifast (MED) down 5.1% since last earnings report: Can it rebound? - MSN
MED News | MEDIFAST INC (NYSE:MED) - ChartMill
Medifast (MED) Down 5.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Is MEDIFAST (MED) Stock Outpacing Its Consumer Staples Peers This Year? - Yahoo Finance
Medifast chief legal officer Jason Groves resigns; company begins search for successor - Investing.com UK
Medifast chief legal officer Jason Groves resigns; company begins search for successor By Investing.com - Investing.com South Africa
Medifast (MED) Files 8-K Announcing Executive Separation Agreement with Jason Groves - Minichart
Medifast's Jason L. Groves resigns as Chief Legal Officer & Corporate Secretary - TradingView
[8-K] MEDIFAST INC Reports Material Event - Stock Titan
MED News Today | Why did Medifast stock drop today? $MED - MarketBeat
Medifast (MED) director takes equity awards instead of cash for board service - Stock Titan
Medifast (NYSE: MED) director Kiai Parsa takes equity grants in lieu of cash fees - Stock Titan
Medifast (MED) director receives 11,680 RSUs as annual fee compensation - Stock Titan
Medifast (NYSE: MED) director receives 11,680 restricted stock units award - Stock Titan
Medifast (NYSE: MED) director awarded 11,680 restricted stock units in fee grant - Stock Titan
Cash-settled RSU grant boosts Medifast (MED) director derivative holdings - Stock Titan
Medifast Inc (NYSE: MED) director Jeffrey Rose files routine Form 3 - Stock Titan
Medifast (NYSE: MED) director details 657,590 indirect shares - Stock Titan
What is Zacks Research's Forecast for Medifast Q2 Earnings? - MarketBeat
Medifast Appoints Nicholas Johnson as New CEO and Amends 2012 Share Incentive Plan - Minichart
Medifast Names Nicholas Johnson as CEO - Moomoo
Medifast Taps Johnson to Succeed Chard as CEO - Moomoo
Medifast names Nicholas Johnson as CEO effective June 1 By Investing.com - Investing.com South Africa
Nicholas Johnson becomes Medifast (NYSE: MED) CEO as investors back equity plan - Stock Titan
Medifast, Inc. Approves Board Elections - marketscreener.com
Medifast names Nicholas Johnson as CEO effective June 1 - Investing.com
Medifast confirms appointment of Nicholas Johnson as chief executive officer - marketscreener.com
Medifast Confirms Appointment of Nicholas Johnson as Chief Executive Officer - Business Wire
Medifast reconfirms $270M-$300M 2026 revenue outlook as it targets profitability improvements starting in Q4 2026 - MSN
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - Sahm
The Human Layer in Weight Management: What OPTAVIA's Coaching Model Is Built to Do - GlobeNewswire Inc.
Weight Loss Coaching vs. App-Only Programs: What Published Research Shows About Long-Term Outcomes - Sahm
MEDIFAST INC (MED) Surges +1.12%, Nearing $13.22 Resistance 2026-05-19Call Spread Alert - thelegaladvocate.com
Citadel reports 6.5% stake in MEDIFAST (MED) in joint Schedule 13G - Stock Titan
MED | Medifast, Inc. FinancialsIncome Statement - Quiver Quantitative
Charles Schwab (MED) reports 631,539 shares, 5.74% stake (03/31/2026) - Stock Titan
Renaissance Holdings amends Schedule 13G: 773,710 shares in MED (MED) - Stock Titan
Why Medifast's $15 Cash Per Share Makes It A Strong Buy (NYSE:MED) - Seeking Alpha
Medifast director Scott Schlackman buys $62,950 in company stock By Investing.com - Investing.com Nigeria
Medifast director Scott Schlackman buys $62,950 in company stock - Investing.com
Medifast (MED) director Scott Schlackman adds 5,000 shares in open-market buys - Stock Titan
TradingKey - TradingKey
Medifast: Worth Putting On A Watchlist (NYSE:MED) - Seeking Alpha
MED Technical Analysis | Trend, Signals & Chart Patterns | MEDIFAST INC (NYSE:MED) - ChartMill
Why is Medifast stock surging despite weak Q1? $30M cost-cut plan - MSN
Document - SEC.gov
Medifast Q1 Loss Narrower Than Expected, Revenues Decline Y/Y - The Globe and Mail
Medifast Inc (MED) 財務データ
収益
当期純利益
現金流量
EPS
1.36%
大文字化:
|
ボリューム (24 時間):